Acticlate FDA Approval History
FDA Approved: Yes (First approved July 25, 2014)
Brand name: Acticlate
Generic name: doxycycline hyclate
Dosage form: Tablets
Company: Almirall, LLC
Treatment for: Bacterial Infection, Acne
Acticlate (doxycycline hyclate) is a tetracycline-class antibacterial indicated for the treatment of a number of infections, including adjunctive therapy in severe acne.
Development timeline for Acticlate
| Date | Article |
|---|---|
| Jul 28, 2014 | Approval Aqua Pharmaceuticals Announces FDA Approval of Acticlate (doxycycline hyclate USP) Tablets |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
